Table 3

Paired analyses comparing the prevalence and transcript levels of gametocyte stage markers between bone marrow and peripheral blood

PrevalenceRelative transcript copy number*
Peripheral bloodBone marrow–Peripheral blood
Bone marrowPositiveNegativePn > 0n < 0Median§Interquartile rangeP
Early         
 Positive 13 <.001 15 0.098 0.043, 0.295 .004 
 Negative       
Intermediate         
 Positive 13 <.001 16 0.210 0.034, 1.696 <.001 
 Negative       
Mature         
 Positive 15 .032 10 0.110 −0.047, 1.539 .148 
 Negative       
PrevalenceRelative transcript copy number*
Peripheral bloodBone marrow–Peripheral blood
Bone marrowPositiveNegativePn > 0n < 0Median§Interquartile rangeP
Early         
 Positive 13 <.001 15 0.098 0.043, 0.295 .004 
 Negative       
Intermediate         
 Positive 13 <.001 16 0.210 0.034, 1.696 <.001 
 Negative       
Mature         
 Positive 15 .032 10 0.110 −0.047, 1.539 .148 
 Negative       

n = 16 paired samples.

*

Ratio between copy numbers of gametocyte transcripts and P falciparum ubiquitin-conjugating enzyme transcript.

Prevalences were compared using the McNemar test.

Number of pairs showing a higher (n > 0) or lower (n < 0) copy number of transcripts in bone marrow compared with peripheral blood.

§

Median of the difference.

Relative transcript copy numbers were compared using the Wilcoxon signed-rank test.

Close Modal

or Create an Account

Close Modal
Close Modal